diclofenac has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nehru, B; Piplani, H; Rana, C; Sanyal, SN; Vaish, V | 1 |
| Dejkriengkraikul, P; Lae Lae Phoo, N; Sukhamwang, A; Yodkeeree, S | 1 |
2 other study(ies) available for diclofenac and cyclin d1
| Article | Year |
|---|---|
Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Curcumin; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Diclofenac; Humans; Oncogene Proteins; Telomerase | 2015 |
Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways.
Topics: Antioxidants; Apoptosis; Autophagy; Carcinoma, Signet Ring Cell; Cisplatin; Cyclin D1; Diclofenac; Drug Resistance, Neoplasm; Humans; NF-E2-Related Factor 2; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms; Transcription Factor AP-1 | 2022 |